 CARLSBAD, Calif., Sept. 3, 2021 PRNewswire -- Ionis Pharmaceuticals, Inc. NASDAQ: IONS, the leader in RNA-targeted therapies, announced today it will present 14 posters and two symposiums highlighting new scientific insights from its ATTR amyloidosis portfolio at the 3rd European ATTR Amyloidosis EU-ATTR meeting for Patients and Doctors on September 6-8, 2021. 